Results 51 to 60 of about 10,579 (231)

Effectiveness of high dose sublingual immunotherapy to induce a stepdown of seasonal asthma: a pilot study [PDF]

, 2009
There is ample evidence to support the efficacy of sublingual immunotherapy (SLIT) on allergic rhinitis, while there is less solid data regarding asthma.
Bignardi, D, Di Cara, G, Frati, F., Incorvaia, C, LA GRUTTA, Stefania, Marcucci, F, Troise, C, Voltolini, S   +7 more
core   +2 more sources

A case of food and aeroallergen sublingual immunotherapy inducing eosinophilic esophagitis

Journal of Allergy and Clinical Immunology: Global, 2023
Eosinophilic esophagitis (EoE) has been reported secondary to aeroallergen sublingual immunotherapy (SLIT) and food allergen oral immunotherapy. Gastrointestinal symptoms with food allergen SLIT are uncommon, with no prior reports of cases of food ...
Maureen Bauer, MD, Dan Atkins, MD, Nathalie Nguyen, MD   +2 more
doaj   +1 more source

30 years of sublingual immunotherapy [PDF]

Allergy, 2019
AbstractAllergen Immunotherapy (AIT) was introduced in clinical practice on an empirical basis more than 100 years ago. Since the first attempts, AIT was administered subcutaneously. Indeed, other routes of administration were proposed and studied, in particular to improve the safety, but only the sublingual route (SLIT) achieved a credibility based on
Passalacqua, Giovanni, Bagnasco, Diego, Canonica, Giorgio Walter   +2 more
openaire   +2 more sources

Peanut Component‐Specific IgE and IgG4 Are Modulated by Sublingual Immunotherapy and Are Associated With Remission in 1–4‐Year‐Old Children

Allergy, EarlyView.
This study presents a post hoc analysis of longitudinal changes in peanut component‐specific IgE and IgG4 in children aged 1–4 years undergoing peanut SLIT, aiming to uncover immune mechanisms and potential biomarkers of remission. Peanut SLIT reduced IgE and increased IgG4 responses to Ara h 1, Ara h 2, Ara h 3, and Ara h 6.
Neel Singh, Janelle Kesselring, Jess Humphrey, Lauren Herlihy, A. Wesley Burks, Johanna Smeekens, Corinne Keet, J. Andrew Bird, Edwin H. Kim, Michael Kulis   +9 more
wiley   +1 more source

Safety and tolerability of seasonal ultra-rush, high-dose sublingual-swallow immunotherapy in allergic rhinitis to grass and tree pollens: an observational study in 193 children and adolescents [PDF]

, 2009
We conducted a large observational study in 193 children and adolescents with allergic rhinitis due to grass or tree pollens to evaluate the safety and tolerability of an ultrarush high-dose sublingual immunotherapy (SLIT) regimen reaching a maintenance ...
Bauer, C, LA GRUTTA, Stefania, Pajno, G, Seidenberg, J, Sieber, J.   +4 more
core  

Protocol for a randomised, double-blind, placebo-controlled study of grass allergen immunotherapy tablet for seasonal allergic rhinitis: time course of nasal, cutaneous and immunological outcomes

, 2015
BACKGROUND: Seasonal Allergic Rhinitis is characterised by inflammation of the nasal mucosa upon exposure to common aeroallergens, affecting up to 20-25 % of the population.
Andersen, PS, Calderón, M, Dumitru, A, Durham, SR, Eifan, A, James, LK, Koulias, C, Lao-Araya, M, Penagos, M, Scadding, G, Shamji, M, Steveling, EH   +11 more
core   +1 more source

Specific allergen immunotherapy for the treatment of atopic eczema. [PDF]

, 2015
BACKGROUND: Specific allergen immunotherapy (SIT) is a treatment that may improve disease severity in people with atopic eczema (AE) by inducing immune tolerance to the relevant allergen.
Boyle, RJ, Calderon, MA, Durham, S, García Núñez, I, Manikam, L, Nankervis, H, Tam, H, Williams, HC   +7 more
core   +2 more sources

Local side effects during sublingual allergen-specific immunotherapy and pathogenetically based methods for their correction (Review)

Аллергология и Иммунология в Педиатрии
Introduction. The study of the effectiveness and safety of allergen-specific immunotherapy remains relevant due to the emergence of a personalized approach in allergology and new dosage forms.
V. Ya. Zakurskaya
doaj   +1 more source

Long‐Term Effect of Allergen Immunotherapy in Responder Local Allergic Rhinitis Patients: Symptom Control, and Prevention of Asthma and Allergic Sensitizations

Allergy, EarlyView.
LAR patients who respond to AIT during the first year and are treated for two more years continue improving (less symptoms and medication intake) during the following seven years. AIT prevents the onset of asthma and allergic sensitizations in responder LAR individuals during the seven years following discontinuation.
Almudena Testera‐Montes, Laura Zubiaga‐Fernandez, Carlos J. Aranda, Irene Garcia‐Esteban, Trinidad Ilda Gaitan‐Nievas, Dulce Sanchez‐Torralvo, Cristobalina Mayorga, Maria J. Torres, Ibon Eguiluz‐Gracia, Carmen Rondon   +9 more
wiley   +1 more source

Sublingual immunotherapy: administration, dosages, use [PDF]

, 2009
Allergen extracts for sublingual immunotherapy (SLIT) are currently marketed by several manufacturers, with administration schedules and amount of allergen(s) quite variable in the different products, although almost all are standardized biologically or ...
Bernardini, R, Frati, F, Incorvaia, C., LA GRUTTA, Stefania, Puccinelli, P, Riario Sforza, G, Scurati, S, Zampogna, S   +7 more
core